Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Diez Domingo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Anales De Pediatria (Barcelona, Spain : 2003)|January 27, 2015
[Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)]P Navarro-Illana, P Caballero, J Tuells, et al.
Vaccine|July 25, 2006
Economic evaluation of varicella vaccination in Spain: results from a dynamic modelX Lenne, J Diez Domingo, A Gil, et al.
Anales Espanoles De Pediatria|April 1, 1993
[Benign myoclonus in infancy]P Martinez Pastor, J Diez Domingo, A Ausina Gomez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2009
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmesS Ladhani, P T Heath, M P E Slack, et al.
Public Health|March 16, 2016
Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination systemA M Alguacil-Ramos, J Muelas-Tirado, T M Garrigues-Pelufo, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|January 29, 2009
[Vaccination schedule of the Spanish association of pediatrics: recommendations 2009]E Bernaola Iturbe, F Giménez Sánchez, M Baca Cots, et al.
Human Vaccines|October 3, 2006
Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccinationJ Diez-Domingo, A Gil, M San-Martín, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Vaccine|November 29, 2022
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort studyC Willame, C Dodd, C E Durán, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anales De Pediatria (Barcelona, Spain : 2003)|January 27, 2015
[Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)]P Navarro-Illana, P Caballero, J Tuells, et al.
Vaccine|July 25, 2006
Economic evaluation of varicella vaccination in Spain: results from a dynamic modelX Lenne, J Diez Domingo, A Gil, et al.
Anales Espanoles De Pediatria|April 1, 1993
[Benign myoclonus in infancy]P Martinez Pastor, J Diez Domingo, A Ausina Gomez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2009
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmesS Ladhani, P T Heath, M P E Slack, et al.
Public Health|March 16, 2016
Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination systemA M Alguacil-Ramos, J Muelas-Tirado, T M Garrigues-Pelufo, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|January 29, 2009
[Vaccination schedule of the Spanish association of pediatrics: recommendations 2009]E Bernaola Iturbe, F Giménez Sánchez, M Baca Cots, et al.
Human Vaccines|October 3, 2006
Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccinationJ Diez-Domingo, A Gil, M San-Martín, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Vaccine|November 29, 2022
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort studyC Willame, C Dodd, C E Durán, et al.
Pageof 1